spacer logo  

 
 
 
 
 
 
 
 


PRESS RELEASES

CLINILABS TO EXHIBIT AT CPT 2008

Québec City, Canada (July 22, 2008) – Clinilabs, Inc., a specialty contract research organization (CRO), will be exhibiting at the IXth World Conference on Clinical Pharmacology and Therapeutics, scheduled to take place from July 27th through August 1st at the Québec City Convention Centre.  Approximately 2,500 professionals from around the world are expected to attend, including physicians, pharmacists, and researchers. 

 

CPT World Conference is an international meeting, held every four years.  It is a forum for clinical and basic pharmacologists from all across the world to gather and discuss the recent advances in drug research and utilization.

 

“CPT is a great opportunity to present Clinilabs’ Phase I capabilities to sponsors who are looking for a high standard of service,” stated Dr. Gary Zammit, Clinilabs’ President & CEO.  “Furthermore, we believe that the recent expansion of our Phase I facility and our diverse local subject population will make Clinilabs the preferred choice for sponsors seeking exceptional service,” he added.

 

Clinilabs’ 68-bed, state-of-the-art Phase I facility is an ideal location for Phase I studies in any therapeutic area, including pharmacokinetic (PK), pharmacodynamic (PD), bioavailability (BA), bioequivalence (BE), drug interaction, and food interaction studies.  Conveniently located in New York City, Clinilabs can recruit patients from a large and diverse community, including healthy adult, healthy elderly, Japanese, Chinese, and key clinical populations. 

 

Cognitive Drug Research (CDR), Clinilabs’ strategic partner and leading provider of cognitive assessment services to the pharmaceutical industry, will also be exhibiting at this event.  CDR will present a poster on “Translational Medicine: Benefits of Computerized Cognitive Function Assessment in Routine Phase I Safety and Tolerability Trials of Cognition Enhancers." 

 

Clinilabs will have applications available on-site for its investigator database, the Company’s primary resource for identifying qualified investigators for participation in multicenter clinical trials.  Investigators who join the database are eligible for free, Web-based clinical trial training and CE credit for themselves and their site personnel. 

 

Visit Clinilabs at booth #104 to learn more about our services and pick up an application for our investigator database.  Also take part in our raffle for a Nintendo’s Wii!

About Clinilabs, Inc.

Clinilabs is a specialty contract research organization (CRO) that provides a full portfolio of services to pharmaceutical, biotechnology, and medical device companies involved in the development of central nervous system (CNS) and cardiovascular (CV) therapeutics.  The Company also provides early phase services in a wider range of therapeutic areas at its Phase I facility.  Established in 2001, Clinilabs has provided services to more than one third of the world’s top 20 pharmaceutical companies, and has been involved in 7 successful New Drug Applications (NDAs) in central nervous system (CNS) and cardiovascular (CV) indications.  For more information, please visit www.clinilabs.com.

Contact

For more information about Clinilabs and its exhibit, or to schedule an appointment with one of our representatives, please contact Jeanine Estrada at 212-981-2716 or via e-mail at jestrada@clinilabs.com.

 

For more information on CPT 2008 or to register for the event, please call +1 (613) 993-0414, e-mail cpt2008@nrc-cnrc.gc.ca, or visit www.cpt2008.org.


 
 





 

 
Contact | Privacy Policy and Terms of Use | SiteMap
USA: 423 West 55th Street, 4th Floor New York, NY 10019 • tel: 646.215.6400 • fax: 646.215.6401 • info@clinilabs.com
© Clinilabs, Inc. 2008